Study to Assess Cancer Patients' Satisfaction With Hospital Quality of Care
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00045019 |
Recruitment Status :
Completed
First Posted : January 27, 2003
Last Update Posted : August 27, 2012
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
RATIONALE: Questionnaires may help determine cancer patients' satisfaction with the quality of care they received in the hospital.
PURPOSE: Clinical trial to determine the effectiveness of questionnaires in assessing cancer patients' satisfaction with the quality of care they received in the hospital.
Condition or disease | Intervention/treatment |
---|---|
Unspecified Adult Solid Tumor, Protocol Specific | Other: quality-of-life assessment |
OBJECTIVES:
- Determine the scale structure, reliability, and validity of the QLQ-SAT32 patient satisfaction module in assessing the perception of the quality of care received in hospitals by patients with cancer.
- Determine the success of the QLQ-SAT32 patient satisfaction module when used with the QLQ-C30 core quality of life questionnaire, in terms of expanding on quality of life evaluation or providing information on treatment acceptability or preference of these patients.
OUTLINE: This is a descriptive, multicenter study. Patients are stratified according to age (18 to 49 vs 50 and over) and the cancer therapy received in hospital (surgery vs chemotherapy).
Patients in all strata receive the QLQ-SAT32 and QLQ-C30 questionnaires, a debriefing questionnaire, and the Oberst patient satisfaction visual analog scale prior to hospital discharge. Patients complete the materials at home within 7 days of discharge. A group of 100 patients have a repeat QLQ-SAT32 module mailed to them to be completed within 7 days of receipt of first questionnaire.
PROJECTED ACCRUAL: A total of 640-768 patients (160-192 per stratum) will be accrued for this study.
Study Type : | Observational |
Actual Enrollment : | 795 participants |
Observational Model: | Case-Only |
Time Perspective: | Prospective |
Official Title: | An International Field-Testing Study Of The Reliability And Validity Of A Patient Satisfaction Module (QLQ-SAT32) Assessing Cancer Patients' Perception Of The Quality Of Care Received Within The Hospital |
Study Start Date : | May 2002 |
Actual Primary Completion Date : | June 2004 |
Actual Study Completion Date : | March 2005 |

Group/Cohort | Intervention/treatment |
---|---|
discharged cancer patients
patients discharged from a surgery or medical ward of oncology institutes in Belgium, France, Germany, Italy, Poland, Spain, Sweden, Taiwan and United Kingdom (as part of a larger psychometric validation study) were asked to rate there level of satisfaction, using the EORTC QLQ-SAT32.
|
Other: quality-of-life assessment
QLQ-C30 SAT32
Other Name: QoL |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
DISEASE CHARACTERISTICS:
- Histologically confirmed cancer
- Hospitalization of at least 3 days
- No clinical evidence of brain metastases
PATIENT CHARACTERISTICS:
Age
- 18 and over
Performance status
- Not specified
Life expectancy
- Not specified
Hematopoietic
- Not specified
Hepatic
- Not specified
Renal
- Not specified
Other
- No psychological, familial, sociological, or geographical condition that would preclude study
- Able to understand the language of the questionnaire
- Mentally fit to complete a questionnaire
PRIOR CONCURRENT THERAPY:
Biologic therapy
- Not specified
Chemotherapy
- Prior chemotherapy allowed
Endocrine therapy
- Not specified
Radiotherapy
- Not specified
Surgery
- Prior surgery for cancer allowed
Other
- No concurrent participation in other quality of life studies that would preclude this study

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00045019
Belgium | |
Institut Jules Bordet | |
Brussels, Belgium, 1000 | |
France | |
Institut Bergonie | |
Bordeaux, France, 33076 | |
Centre Regional Francois Baclesse | |
Caen, France, 14076 | |
Institut Curie - Section Medicale | |
Paris, France, 75231 | |
Centre Paul Strauss | |
Strasbourg, France, 67085 | |
Centre Alexis Vautrin | |
Vandoeuvre-les-Nancy, France, 54511 | |
Institut Gustave Roussy | |
Villejuif, France, F-94805 | |
Spain | |
Hospital De Navarra | |
Pamplona, Spain, 31008 | |
Sweden | |
Sahlgrenska University Hospital | |
Gothenburg, Sweden, S-413 45 | |
Uppsala University Hospital | |
Uppsala, Sweden, S-75183 | |
United Kingdom | |
Bristol Royal Infirmary | |
Bristol, United Kingdom, BS2 8HW |
Study Chair: | Anne Bredart | Institut Curie |
Responsible Party: | European Organisation for Research and Treatment of Cancer - EORTC |
ClinicalTrials.gov Identifier: | NCT00045019 History of Changes |
Other Study ID Numbers: |
EORTC-15012 EORTC-15012 ( Other Identifier: EORTC ) |
First Posted: | January 27, 2003 Key Record Dates |
Last Update Posted: | August 27, 2012 |
Last Verified: | August 2012 |
Keywords provided by European Organisation for Research and Treatment of Cancer - EORTC:
unspecified adult solid tumor, protocol specific |